BigHat Biosciences

Overview

Designs AI-guided antibody therapeutics using automated wet-lab data generation to help drug development teams optimize multiple biological properties for clinical programs.

Timeline

1. Sep 2026series-c-plus · $75Mthepharmaletter.com ↗